JP6605036B2 - 肝臓及び腎臓の損傷関連疾患を予防し又は治療する中医薬組成物の調製法 - Google Patents
肝臓及び腎臓の損傷関連疾患を予防し又は治療する中医薬組成物の調製法 Download PDFInfo
- Publication number
- JP6605036B2 JP6605036B2 JP2017544807A JP2017544807A JP6605036B2 JP 6605036 B2 JP6605036 B2 JP 6605036B2 JP 2017544807 A JP2017544807 A JP 2017544807A JP 2017544807 A JP2017544807 A JP 2017544807A JP 6605036 B2 JP6605036 B2 JP 6605036B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- group
- liver
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004185 liver Anatomy 0.000 title claims description 42
- 238000000034 method Methods 0.000 title claims description 22
- 210000003734 kidney Anatomy 0.000 title claims description 19
- 239000000203 mixture Substances 0.000 title claims description 16
- 230000006378 damage Effects 0.000 title description 6
- 201000010099 disease Diseases 0.000 title description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000007864 aqueous solution Substances 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 18
- 239000000341 volatile oil Substances 0.000 claims description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 16
- 235000002597 Solanum melongena Nutrition 0.000 claims description 13
- 244000061458 Solanum melongena Species 0.000 claims description 13
- 241000209140 Triticum Species 0.000 claims description 13
- 235000021307 Triticum Nutrition 0.000 claims description 13
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 12
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 12
- 230000005070 ripening Effects 0.000 claims description 12
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 11
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 11
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 11
- 239000011425 bamboo Substances 0.000 claims description 11
- 241000411851 herbal medicine Species 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000003640 drug residue Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 240000008067 Cucumis sativus Species 0.000 claims description 6
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 241000723353 Chrysanthemum Species 0.000 claims 2
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 description 53
- 239000003814 drug Substances 0.000 description 42
- 210000002966 serum Anatomy 0.000 description 39
- 206010067125 Liver injury Diseases 0.000 description 35
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical group C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 33
- 231100000753 hepatic injury Toxicity 0.000 description 27
- 229940079593 drug Drugs 0.000 description 26
- 235000019441 ethanol Nutrition 0.000 description 25
- 239000000243 solution Substances 0.000 description 21
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 20
- 108010082126 Alanine transaminase Proteins 0.000 description 20
- 241000700159 Rattus Species 0.000 description 20
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 19
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 18
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 18
- 210000003494 hepatocyte Anatomy 0.000 description 18
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 16
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 15
- 238000011552 rat model Methods 0.000 description 15
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 15
- 229960001225 rifampicin Drugs 0.000 description 15
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 14
- 230000002440 hepatic effect Effects 0.000 description 14
- 229960004245 silymarin Drugs 0.000 description 14
- 235000017700 silymarin Nutrition 0.000 description 14
- 210000005228 liver tissue Anatomy 0.000 description 13
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 12
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 11
- 229960004397 cyclophosphamide Drugs 0.000 description 11
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 11
- 241001330002 Bambuseae Species 0.000 description 10
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 10
- 229940118019 malondialdehyde Drugs 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 240000005250 Chrysanthemum indicum Species 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 8
- 230000017074 necrotic cell death Effects 0.000 description 8
- 229940116269 uric acid Drugs 0.000 description 8
- 208000004930 Fatty Liver Diseases 0.000 description 7
- 206010019708 Hepatic steatosis Diseases 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000001476 alcoholic effect Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000007850 degeneration Effects 0.000 description 7
- 208000010706 fatty liver disease Diseases 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 231100000240 steatosis hepatitis Toxicity 0.000 description 7
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 210000003855 cell nucleus Anatomy 0.000 description 6
- 229940109239 creatinine Drugs 0.000 description 6
- 231100000234 hepatic damage Toxicity 0.000 description 6
- 230000008818 liver damage Effects 0.000 description 6
- 238000010172 mouse model Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 102000015779 HDL Lipoproteins Human genes 0.000 description 5
- 108010010234 HDL Lipoproteins Proteins 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 239000003937 drug carrier Substances 0.000 description 5
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 5
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 5
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 210000004969 inflammatory cell Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 229940100688 oral solution Drugs 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 235000011511 Diospyros Nutrition 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 231100000481 chemical toxicant Toxicity 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000216 vascular lesion Toxicity 0.000 description 3
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000439 acute liver injury Toxicity 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000005976 liver dysfunction Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 239000003186 pharmaceutical solution Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001083548 Anemone Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 244000089654 Betula populifolia Species 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000981595 Zoysia japonica Species 0.000 description 1
- 230000007488 abnormal function Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229940062353 acid jelly Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 239000008609 bushi Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- -1 tinctures Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Description
揮発油を除去した当帰、川きゅう、菊花、柴胡、九節菖蒲及び陳皮の水溶物の非アルコール沈殿物と、
揮発油を除去しかつ水溶液を除去した当帰、川きゅう、菊花、柴胡、九節菖蒲及び陳皮の水抽出物の非アルコール沈殿物と、
玉竹、枸杞子、麦冬、決明子、白芍及び熟地黄の水抽出物の非アルコール沈殿物。
(2)工程(1)で得られた薬渣と玉竹、枸杞子、麦冬、決明子、白芍及び熟地黄とを混合しかつ加水して煎じ、濾液を工程(1)で得られた水溶液と混合し、濃縮し、アルコール濃度を高め、上澄液を取りアルコールを回収した後に、濾過かつ濃縮し、清膏を得る工程と、
(3)工程(2)で得られた清膏と工程(1)で得られた揮発油とを混合する工程。
(2)工程(1)で得られた薬渣と玉竹、枸杞子、麦冬、決明子、白芍及び熟地黄とを混合しかつ加水して煎じ、濾液を工程(1)で得られた水溶液と混合し、濃縮し、アルコール濃度を高め、上澄液を取りアルコールを回収した後に、濾過かつ濃縮し、清膏を得る工程と、
(3)工程(2)で得られた清膏と工程(1)で得られた揮発油とを混合する工程。
(2)工程(1)で得られた薬渣と玉竹、枸杞子、麦冬、決明子、白芍及び熟地黄とを混合しかつ加水して煎じ、濾液を工程(1)で得られた水溶液と混合し、濃縮し、アルコール濃度を高め、上澄液を取りアルコールを回収した後に、濾過かつ濃縮し、清膏を得る工程と、
(3)工程(2)で得られた清膏と、工程(1)で得られた揮発油及び薬学上許容可能な担体とを混合する工程。
(2)工程(1)で得られた薬渣と玉竹、枸杞子、麦冬、決明子、白芍及び熟地黄とを混合しかつ加水して煎じ、濾液を工程(1)で得られた水溶液と混合し、濃縮し、アルコール濃度を高め、上澄液を取りアルコールを回収した後に、濾過かつ濃縮し、清膏を得る工程と、
(3)工程(2)で得られた清膏と、工程(1)で得られた揮発油及び薬学上許容可能な担体とを混合する工程。
Claims (2)
- 玉竹100−200重量部と、枸杞子100−200重量部と、麦冬80−160重量部と、当帰70−130重量部と、決明子70−130重量部と、白芍70−130重量部と、陳皮70−130重量部と、熟地黄70−130重量部と、菊花70−130重量部と、川きゅう30−70重量部と、九節菖蒲20−40重量部と、柴胡10−20重量部との生薬で生成される肝臓及び腎臓の保護に用いる中医薬組成物の調製法において、
(1)当帰、川きゅう、菊花、柴胡、九節菖蒲及び陳皮を粉砕して混合し、加水蒸留し、揮発油、水溶液及び水不溶性の薬渣を得る工程と、
(2)工程(1)で得られた薬渣と玉竹、枸杞子、麦冬、決明子、白芍及び熟地黄とを混合しかつ加水して煎じ、濾液を工程(1)で得られた水溶液と混合し、濃縮し、アルコール濃度を高め、上澄液を取りアルコールを回収した後に、濾過かつ濃縮し、清膏(エキス)を得る工程と、
(3)工程(2)で得られた清膏と工程(1)で得られた揮発油とを混合する工程とを含むことを特徴とする中医薬組成物の調製法。 - 加水して煎じる工程は、1回0.5〜3時間、1〜3回加水して煎じる工程を含み、
アルコール濃度を高める工程は、濾液と工程(1)で得られた水溶液とを混合し濃縮した後、アルコールとしてエタノールを加えて、60%(V/V)エタノールとする工程を含む請求項1に記載の中医薬組成物の調製法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410646052 | 2014-11-15 | ||
CN201410646052.6 | 2014-11-15 | ||
PCT/CN2015/000296 WO2016074333A1 (zh) | 2014-11-15 | 2015-04-29 | 预防或治疗肝肾损伤相关疾病的药物或保健品及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017537150A JP2017537150A (ja) | 2017-12-14 |
JP6605036B2 true JP6605036B2 (ja) | 2019-11-13 |
Family
ID=55953647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017544807A Active JP6605036B2 (ja) | 2014-11-15 | 2015-04-29 | 肝臓及び腎臓の損傷関連疾患を予防し又は治療する中医薬組成物の調製法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US11160842B2 (ja) |
JP (1) | JP6605036B2 (ja) |
CN (1) | CN107206042B (ja) |
AU (1) | AU2015345884C1 (ja) |
WO (1) | WO2016074333A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107582843A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 一种用于滋补肝肾的配方及其提取工艺 |
US20200237847A1 (en) * | 2019-01-27 | 2020-07-30 | Christopher Kitalong | Herbal composition for metabolic syndromes and method of treatment thereof |
CN112535716B (zh) * | 2019-09-20 | 2022-04-15 | 江阴持一堂医药科技有限公司 | 一种用于治疗酒精性肝损伤的颗粒剂及其制备方法和应用 |
CN115364169B (zh) * | 2022-04-07 | 2024-02-06 | 中国科学院合肥物质科学研究院 | 抗幽门螺杆菌的中药组合物及其制备方法与应用 |
CN116350706B (zh) * | 2023-03-07 | 2024-02-06 | 黑龙江省中医药科学院 | 一种治疗糖尿病性阳痿的中药组合物及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100415275C (zh) | 2005-09-29 | 2008-09-03 | 李广中 | 一种补肝汤 |
JP2007153888A (ja) | 2005-11-14 | 2007-06-21 | Kanebo Foods Ltd | 体内浄化用組成物、それを用いた食品、入浴剤、化粧料、製剤及び有害金属***促進剤 |
CN101716280B (zh) | 2009-12-23 | 2011-11-09 | 刘建国 | 一种用于治疗肝癌的药物组合物 |
CN102138661A (zh) * | 2010-02-02 | 2011-08-03 | 孔赟荣 | 一种乌发豆的配方与制成方法 |
CN101940758B (zh) | 2010-08-19 | 2012-01-18 | 王尚瑞 | 一种治疗肝病的中药组合物及其制备方法和用途 |
CN101972340B (zh) * | 2010-10-08 | 2012-01-25 | 张继成 | 一种补肝明目的中药组合物 |
CN102526473B (zh) | 2012-03-21 | 2013-05-29 | 张蓉 | 一种治疗慢性乙型病毒性肝炎的药剂 |
CN102813857A (zh) * | 2012-07-24 | 2012-12-12 | 辽宁康辰药业有限公司 | 一种中药丝萸养血益肾制剂 |
CN103211918B (zh) * | 2013-04-28 | 2014-03-12 | 张电达 | 一种用于补肾壮阳的鹿角盘酒及其制备方法 |
CN103330785B (zh) * | 2013-06-03 | 2015-05-27 | 安徽华佗国药股份有限公司 | 一种益气养血、滋补肝肾的药物的制备方法 |
CN103463404B (zh) | 2013-08-26 | 2015-04-29 | 杨启阳 | 一种治疗肝肾阴虚的中药组合物 |
CN104000128A (zh) * | 2014-06-09 | 2014-08-27 | 山东百和药业有限公司 | 一种具有滋补肝肾、调理五脏、抗老防衰作用的中药炮制黑豆及其生产方法 |
CN104189449A (zh) * | 2014-08-20 | 2014-12-10 | 张泽文 | 一种治疗肝肾亏虚型腰椎间盘突出症的中药组合物 |
-
2015
- 2015-04-29 JP JP2017544807A patent/JP6605036B2/ja active Active
- 2015-04-29 AU AU2015345884A patent/AU2015345884C1/en active Active
- 2015-04-29 US US15/526,870 patent/US11160842B2/en active Active
- 2015-04-29 WO PCT/CN2015/000296 patent/WO2016074333A1/zh active Application Filing
- 2015-04-29 CN CN201580062031.2A patent/CN107206042B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107206042A (zh) | 2017-09-26 |
US11160842B2 (en) | 2021-11-02 |
AU2015345884C1 (en) | 2021-10-28 |
JP2017537150A (ja) | 2017-12-14 |
WO2016074333A8 (zh) | 2016-06-30 |
AU2015345884B2 (en) | 2021-07-29 |
WO2016074333A1 (zh) | 2016-05-19 |
AU2015345884A1 (en) | 2017-06-08 |
US20190167752A1 (en) | 2019-06-06 |
CN107206042B (zh) | 2018-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5184090B2 (ja) | 高脂血症を治療及び/又は予防する医薬組成物、その製法及びその使用 | |
JP6797202B2 (ja) | 参苓白朮顆粒およびその調製方法 | |
JP6605036B2 (ja) | 肝臓及び腎臓の損傷関連疾患を予防し又は治療する中医薬組成物の調製法 | |
CN1931270B (zh) | 中药醒酒护肝药剂及其制备方法 | |
KR20150096798A (ko) | 두통을 치료하기 위한 약학적 조성물 및 그의 제조방법 | |
CN101816723B (zh) | 中药醒酒护肝药剂及其制备方法 | |
CN104815138A (zh) | 一种枳实提取物、制剂及用途 | |
CN107375882A (zh) | 一种保心宁颗粒的制备方法 | |
CN106344631A (zh) | 柳兰有效部位及其制备方法和应用 | |
JP2007016053A (ja) | 抗悪性腫瘍剤 | |
CN102670956B (zh) | 一种中药组合物在制备抗心肌细胞凋亡和/或抗心肌细胞凋亡相关疾病的药物中的应用 | |
CN101744993B (zh) | 人参、麦冬、五味子的提取方法及其制剂 | |
JP2005194256A (ja) | 肝臓病治療用医薬組成物及びその製造方法 | |
CN101744991B (zh) | 一种人参、麦冬、五味子的单独提取方法及其制剂 | |
CN101745011B (zh) | 一种人参、麦冬和五味子的提取方法及其制剂 | |
CN101745012B (zh) | 一种人参/麦冬和五味子的提取方法及其制剂 | |
CN101745017B (zh) | 一种人参、麦冬以及五味子的提取方法及其制剂 | |
JPH0930983A (ja) | アポトーシス抑制剤 | |
CN104258034A (zh) | 一种增强免疫力的中药组合物 | |
CN103800449B (zh) | 一种治疗阴虚热盛证2型糖尿病的中药组合物 | |
CN104069312B (zh) | 治疗中风的中药组合物及其制备方法、药物制剂和应用 | |
CN102652791A (zh) | 一种具有抗肝纤维化作用的药物组合物及制备方法 | |
CN101745000B (zh) | 一种人参,麦冬和五味子的提取方法及其制剂 | |
CN101744994B (zh) | 人参,麦冬,五味子的提取方法及其制剂 | |
CN101744987B (zh) | 一种人参,麦冬与五味子的单独提取方法及其制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171006 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180305 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181107 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181121 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190214 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190415 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190517 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190925 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191015 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6605036 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |